“The cynomolgus monkey was utilized as the only pharmacologically relevant species for toxicity testing, in view of cross reactivity of MCLA-128 with the HER2/HER3 targets in this species.”
✓ VerifiedFDA multi-discipline review, p. 77Source ↗
Why that species
Binds human and monkey HER2/HER3 (98-99% sequence identity); anti-HER2 Fab does not bind rodent HER2
“Together, these results support the use of cynomolgus monkeys as the pharmacologically relevant species for zenocutuzumab toxicity assessment.”
✓ VerifiedFDA multi-discipline review, p. 57Source ↗
Surrogate molecule
No surrogate; clinical molecule (MCLA-128) tested in cynomolgus monkey
“Toxicokinetic (TK) characteristics of MCLA-128 (zenocutuzumab) were studied as part of single and repeated dose toxicity studies in cynomolgus monkeys, the pharmacologically relevant species.”
✓ VerifiedFDA multi-discipline review, p. 71Source ↗